Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT

Bone Marrow Transplant. 2015 Jan;50(1):142-4. doi: 10.1038/bmt.2014.211. Epub 2014 Sep 29.

Authors

V Bachanova¹, Q Cao², C Ustun¹, A T K Kendi², J Froelich³, A Lazaryan¹, L J Burns¹

Affiliations

¹ Bone and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.
² Statistical Center, University of Minnesota, Minneapolis, MN, USA.
³ Department of Radiology, University of Minnesota, Minneapolis, MN, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Adolescent
Adult
Aged
Allografts
Disease-Free Survival
Female
Fluorodeoxyglucose F18 / administration & dosage*
Humans
Lymphoma, Non-Hodgkin* / diagnostic imaging
Lymphoma, Non-Hodgkin* / mortality
Lymphoma, Non-Hodgkin* / therapy
Male
Middle Aged
Positron-Emission Tomography*
Radiography
Radiopharmaceuticals / administration & dosage*
Stem Cell Transplantation*
Survival Rate

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18

Grants and funding